Quinolinate immunoreactivity in experimental rat brain tumors is present in macrophages but not in astrocytes

Experimental Neurology

Volumn 144, Issue 2, 1997, Pages 287-301

  Moffett, John R ^a   Els, Thomas ^b,d   Espey, Michael G ^a   Walter, Sharon A ^c   Streit, Wolfgang J ^c   Namboodiri, M A Aryan ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; QUINOLINIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CANCER; EXPERIMENTAL NEOPLASM; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; TISSUE DISTRIBUTION;

EID: 17144460369     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.6365     Document Type: Article

References (58)

1. Acarin L., Vela J. M., Gonzalez B., Castellano B. Demonstration of poly-N-acetyl lactosamine residues in ameboid and ramified microglial cells in rat brain by tomato lectin binding. J. Histochem. Cytochem. 42:1994;1033-1041.
2. Bender D. A. The kynurenine pathway of tryptophan metabolism. Quinolinic Acid and the Kynurenines. 1989;CRC Press, Boca Raton. p. 4-38.
3. Boulikas T. Poly(ADP-ribose) synthesis and degradation in mammalian nuclei. Anal. Biochem. 203:1992;252-258.
4. Brew B. J., Pemberton L., Heyes M., Evans L. Quinolinic acid production by macrophages infected with demented and non-demented isolates of HIV. Int. Conf. AIDS. 9:1993;61.
5. Cox G. W., Melillo G., Chattopadhyay U., Mullet D., Fertel R. H., Varesio L. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity. J. Immunol. 149:1992;3290-3296.
6. Daubener W., Pilz K., Seghrouchni Zennati S., Bilzer T., Fischer H. G., Hadding U. Induction of toxoplasmostasis in a human glioblastoma by interferon gamma. J. Neuroimmunol. 43:1993;31-38.
7. Eastman C. L., Urbanska E., Love A., Kristensson K., Schwarcz R. Increased brain quinolinic acid production in mice infected with a hamster neurotropic measles virus. Exp. Neurol. 125:1994;119-124.
8. Espey M. G., Moffett J. R., Namboodiri M. A. Temporal and spatial changes of quinolinic acid immunoreactivity in the immune system of lipopolysaccharide-stimulated mice. J. Leukoc. Biol. 57:1995;199-206.
9. Foster A. C., White R. J., Schwarcz R. Synthesis of quinolinic acid by 3-hydroxyanthranilic acid oxygenase in rat brain tissue in vitro. J. Neurochem. 47:1986;23-30.
10. Giulian D., Vaca K., Noonan C. A. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science. 250:1990;1593-1596.
11. Hancock J. T., White J. I., Jones O. T., Silver I. A. The use of diphenylene iodonium and its analogues to investigate the role of the NADPH oxidase in the tumoricidal activity of macrophages in vitro. Free Rad. Biol. Med. 11:1991;25-29.
12. Hayaishi O., Yoshida R. Specific induction of pulmonary indoleamine 2,3-dioxygenase by bacterial lipopolysaccharide. Ciba Found. Symp. 1978;199-203.
13. Heyes M. P., Saito K., Crowley J. S., Davis L. E., Demitrack M. A., Der M., Dilling L. A., Elia J., Kruesi M. J., Lackner A. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain. 115:1992;1249-1273.
14. Heyes M. P., Saito K., Markey S. P. Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochem. J. 283:1992;633-635.
15. Johnston R. B. Jr., Kitagawa S. Molecular basis for the enhanced respiratory burst of activated macrophages. Fed. Proc. 44:1985;2927-2932.
16. Keller R., Keist R., Erb P., Aebischer T., De Libero G., Balzer M., Groscurth P., Keller H. U. Expression of cellular effector functions and production of reactive nitrogen intermediates: a comparative study including T lymphocytes, T-like cells, neutrophil granulocytes, and mononuclear phagocytes. Cell Immunol. 131:1990;398-403.
17. Ko L., Koestner A., Wechsler W. Morphological characterization of nitrosourea-induced glioma cell lines and clones. Acta Neuropathol. (Berl). 51:1980;23-31.
18. Köhler C., Eriksson L. G., Flood P. R., Hardie J. A., Okuno E., Schwarcz R. Quinolinic acid metabolism in the rat brain. Immunohistochemical identification of 3-hydroxyanthranilic acid oxygenase and quinolinic acid phosphoribosyltransferase in the hippocampal region. J. Neurosci. 8:1988;975-987.
19. Martin J. H., Edwards S. W. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J. Immunol. 150:1993;3478-3486.
20. McCreanor G. M., Bender D. A. The metabolism of high intakes of tryptophan, nicotinamide and nicotinic acid in the rat. Br. J Nutr. 56:1986;577-586.
21. Melillo G., Cox G. W., Biragyn A., Sheffler L. A., Varesio L. Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid. J. Biol. Chem. 269:1994;8128-8133.
22. Melillo G., Cox G. W., Radzioch D., Varesio L. Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages. J. Immunol. 150:1993;4031-4040.
23. Moffett J. R., Espey M. G., Gaudet S. J., Namboodiri M. A. Antibodies to quinolinic acid reveal localization in select immune cells rather than neurons or astroglia. Brain Res. 623:1993;337-340.
24. Moffett J. R., Espey M. G., Namboodiri M. A. Antibodies to quinolinic acid and the determination of its cellular distribution within the rat immune system. Cell Tissue. Res. 278:1994;461-469.
25. Moffett J. R., Espey M. G., Saito K., Namboodiri M. A. Quinolinic acid immunoreactivity in cells within the choroid plexus, leptomeninges and brain vasculature of the immune stimulated gerbil. J. Neuroimmunol. 54:1994;69-73.
26. Moffett J. R., Namboodiri M. A., Neale J. H. Enhanced carbodiimide fixation for immunohistochemistry: Application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain. J. Histochem. Cytochem. 41:1993;559-570.
27. Morel F., Doussiere J., Vignais P. V. The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects. Eur. J. Biochem. 201:1991;523-546.
28. Morioka T., Baba T., Black K. L., Streit W. J. Immunophenotypic analysis of infiltrating leukocytes and microglia in an experimental rat glioma. Acta Neuropathol. (Berlin). 83:1992;590-597.
29. Okuno E., Köhler C., Schwarcz R. Rat 3-hydroxyanthranilic acid oxygenase: purification from the liver and immunocytochemical localization in the brain. J. Neurochem. 49:1987;771-780.
30. Ozaki Y., Edelstein M. P., Duch D. S. The actions of interferon and antiinflammatory agents of induction of indoleamine 2,3-dioxygenase in human peripheral blood monocytes. Biochem. Biophys. Res. Commun. 144:1987;1147-1153.
31. Pearl R. G., Raffin T. A. Niacin reduces oxygen toxicity in mouse alveolar macrophages. Pharmacology. 27:1983;219-222.
32. Perkins M. N., Stone T. W. Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system. J. Pharmacol. Exp. Ther. 226:1983;551-557.
33. Popovich P. G., Reinhard J. F. Jr., Flanagan E. M., Stokes B. T. Elevation of the neurotoxin quinolinic acid occurs following spinal cord trauma. Brain Res. 633:1994;348-352.
34. Roberts R. C., McCarthy K. E., Du F., Okuno E., Schwarcz R. Immunocytochemical localization of the quinolinic acid synthesizing enzyme, 3-hydroxyanthranilic acid oxygenase, in the rat substantia nigra. Brain Res. 650:1994;229-238.
35. Roos D. The involvement of oxygen radicals in microbicidal mechanisms of leukocytes and macrophages. Klin. Wochenschr. 69:1991;975-980.
36. Ruffmann R., Schlick R., Chirigos M. A., Budzynsky W., Varesio L. Antiproliferative activity of picolinic acid due to macrophage activation. Drugs Exp. Clin. Res. 13:1987;607-614.
37. Saito K., Chen C. Y., Masana M., Crowley J. S., Markey S. P., Heyes M. P. 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells). Biochem. J. 291:1993;11-14.
38. Saito K., Crowley J. S., Markey S. P., Heyes M. P. A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J. Biol. Chem. 268:1993;15496-15503.
39. Saito K., Markey S. P., Heyes M. P. Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice. Brain Res. 546:1991;151-154.
40. Saito K., Markey S. P., Heyes M. P. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neuroscience. 51:1992;25-39.
41. Saito K., Markey S. P., Heyes M. P. 6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation. Neurosci. Lett. 178:1994;211-215.
42. Saito K., Nowak T. S. Jr., Suyama K., Quearry B. J., Saito M., Crowley J. S., Markey S. P., Heyes M. P. Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation. J. Neurochem. 61:1993;2061-2070.
43. Schraufstatter I. U., Hyslop P. A., Hinshaw D. B., Spragg R. G., Sklar L. A., Cochrane C. G. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;4908-4912.
44. Schwarcz R., Whetsell W. O. Jr., Mangano R. M. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science. 219:1983;316-318.
45. Speciale C., Schwarcz R. On the production and disposition of quinolinic acid in rat brain and liver slices. J. Neurochem. 60:1993;212-218.
46. Stone T. W., Connick J. H. Quinolinic acid and other kynurenines in the central nervous system. Neuroscience. 15:1985;597-617.
47. Stone T. W., Connick J. H., Winn P., Hastings M. H., English M. Endogenous excitotoxic agents. Ciba Found. Symp. 126:1987;204-220.
48. Streit W. J. An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4). J. Histochem. Cytochem. 38:1990;1683-1686.
49. Sun Y. Indoleamine 2,3-dioxygenase - a new antioxidant enzyme. Mater. Med. Pol. 21:1989;244-250.
50. Takikawa O., Habara-Ohkubo A., Yoshida R. IFN-gamma is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection. J. Immunol. 145:1990;1246-1250.
51. Takikawa O., Yoshida R., Kido R., Hayaishi O. Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase. J. Biol. Chem. 261:1986;3648-3653.
52. Varesio L., Clayton M., Blasi E., Ruffman R., Radzioch D. Picolinic acid, a catabolite of tryptophan, as the second signal in the activation of IFN-gamma-primed macrophages. J. Immunol. 145:1990;4265-4271.
53. Venkateshan C. N., Narayanan R., Espey M. G., Moffett J. R., Gajdusek D. C., Gibbs C. J., Namboodiri M. A. Immunocytochemical localization of the endogenous neuroexcitotoxin quinolinate in human peripheral blood monocytes/macrophages and the effect of human T-cell lymphotropic virus type I infection. Proc. Natl. Acad. Sci. USA. 93:1996;1636-1641.
54. Werner E. R., Hirsch-Kauffmann M., Fuchs D., Hausen A., Reibnegger G., Schweiger M., Wachter H. Interferon-gamma-induced degradation of tryptophan by human cells in vitro. Biol. Chem. Hoppe Seyler. 368:1987;1407-1412.
55. Werner-Felmayer G., Werner E. R., Fuchs D., Hausen A., Reibnegger G., Wachter H. Characteristics of interferon induced tryptophan metabolism in human cells in vitro. Biochim. Biophys. Acta. 1012:1989;140-147.
56. Yoshida R., Imanishi J., Oku T., Kishida T., Hayaishi O. Induction of pulmonary indoleamine 2,3-dioxygenase by interferon. Proc. Natl. Acad. Sci. USA. 78:1981;129-132.
57. Yoshida R., Park S. W., Yasui H., Takikawa O. Tryptophan degradation in transplanted tumor cells undergoing rejection. J. Immunol. 141:1988;2819-2823.
58. Yoshida R., Urade Y., Tokuda M., Hayaishi O. Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection. Proc. Natl. Acad. Sci. USA. 76:1979;4084-4086.